Ophthalmic drugs.
The author reviews the indications and dosage schedules for various categories of ophthalmic medications. The family physician should be especially alert to the potential systemic side effects that may occur with use of ophthalmic drugs.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001252:Astringents / Q000627:therapeutic use; D002648:Child; D005128:Eye Diseases / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D008916:Miotics / Q000627:therapeutic use; D009184:Mydriatics / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D001252:Astringents; D006634:Histamine H1 Antagonists; D008916:Miotics; D009184:Mydriatics; D009883:Ophthalmic Solutions; D010276:Parasympatholytics; D013256:Steroids